Vol. 76 Monday, 

No. 147 August 1, 2011 

Part V 

Environmental Protection Agency 

Sixty-Eighth Report of the TSCA Interagency Testing Committee to the 

Administrator of the Environmental Protection Agency; Receipt of Report 

and Request for Comments; Notice 


sroberts on DSK5SPTVN1PROD with NOTICES
46174 Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 

ENVIRONMENTAL PROTECTION 

AGENCY 

[EPA–HQ–OPPT–2011–0437; FRL–8879–3] 

Sixty-Eighth Report of the TSCA 

Interagency Testing Committee to the 

Administrator of the Environmental 

Protection Agency; Receipt of Report 

and Request for Comments 

AGENCY: Environmental Protection 

Agency (EPA). 

ACTION: Notice. 

SUMMARY: The Toxic Substances Control 

Act (TSCA) Interagency Testing 

Committee (ITC) transmitted its SixtyEighth Report to the Administrator of 

EPA on June 14, 2011. In the 68th ITC 

Report, which is included with this 

notice, the ITC is adding cadmium and 

103 cadmium compounds to TSCA 

section 4(e) Priority Testing List. During 

this reporting period (December 2010 to 

May 2011), the ITC is also removing 29 

High Production Volume (HPV) 

Challenge Program orphan chemicals 

and lead and 11 lead compounds from 

the Priority Testing List. 

DATES: Comments must be received on 

or before August 31, 2011. 

ADDRESSES: Submit your comments, 

identified by docket identification (ID) 

number EPA–HQ–OPPT–2011–0437, by 

one of the following methods: 

• Federal eRulemaking Portal: http:// 

www.regulations.gov. Follow the on-line 

instructions for submitting comments. 

• Mail: Document Control Office 

(7407M), Office of Pollution Prevention 

and Toxics (OPPT), Environmental 

Protection Agency, 1200 Pennsylvania 

Ave., NW., Washington, DC 20460– 

0001. 

• Hand Delivery: OPPT Document 

Control Office (DCO), EPA East Bldg., 

Rm. 6428, 1201 Constitution Ave., NW., 

Washington, DC. Attention: Docket ID 

Number EPA–HQ–OPPT–2011–0437. 

The DCO is open from 8 a.m. to 4 p.m., 

Monday through Friday, excluding legal 

holidays. The telephone number for the 

DCO is (202) 564–8930. Such deliveries 

are only accepted during the DCO’s 

normal hours of operation, and special 

arrangements should be made for 

deliveries of boxed information. 

Instructions: Direct your comments to 

docket ID number EPA–HQ–OPPT– 

2011–0437. EPA’s policy is that all 

comments received will be included in 

the docket without change and may be 

made available on-line at http:// 

www.regulations.gov, including any 

personal information provided, unless 

the comment includes information 

claimed to be Confidential Business 

Information (CBI) or other information 

whose disclosure is restricted by statute. 

Do not submit information that you 

consider to be CBI or otherwise 

protected through regulations.gov or email. The regulations.gov Web site is an 

‘‘anonymous access’’ system, which 

means EPA will not know your identity 

or contact information unless you 

provide it in the body of your comment. 

If you send an e-mail comment directly 

to EPA without going through 

regulations.gov, your e-mail address 

will be automatically captured and 

included as part of the comment that is 

placed in the docket and made available 

on the Internet. If you submit an 

electronic comment, EPA recommends 

that you include your name and other 

contact information in the body of your 

comment and with any disk or CD–ROM 

you submit. If EPA cannot read your 

comment due to technical difficulties 

and cannot contact you for clarification, 

EPA may not be able to consider your 

comment. Electronic files should avoid 

the use of special characters, any form 

of encryption, and be free of any defects 

or viruses. 

Docket: All documents in the docket 

are listed in the docket index available 

at http://www.regulations.gov. Although 

listed in the index, some information is 

not publicly available, e.g., CBI or other 

information whose disclosure is 

restricted by statute. Certain other 

material, such as copyrighted material, 

will be publicly available only in hard 

copy. Publicly available docket 

materials are available electronically at 

http://www.regulations.gov, or, if only 

available in hard copy, at the OPPT 

Docket. The OPPT Docket is located in 

the EPA Docket Center (EPA/DC) at Rm. 

3334, EPA West Bldg., 1301 

Constitution Ave., NW., Washington, 

DC. The EPA/DC Public Reading Room 

hours of operation are 8:30 a.m. to 4:30 

p.m., Monday through Friday, excluding 

legal holidays. The telephone number of 

the EPA/DC Public Reading Room is 

(202) 566–1744, and the telephone 

number for the OPPT Docket is (202) 

566–0280. Docket visitors are required 

to show photographic identification, 

pass through a metal detector, and sign 

the EPA visitor log. All visitor bags are 

processed through an X-ray machine 

and subject to search. Visitors will be 

provided an EPA/DC badge that must be 

visible at all times in the building and 

returned upon departure. 

FOR FURTHER INFORMATION CONTACT: For 

technical information contact: John D. 

Walker, Interagency Testing Committee 

(7401M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; telephone 

number: (202) 564–7527; fax number: 

(202) 564–7528; e-mail address: 

walker,johnd@epa.gov. 

For general information contact: The 

TSCA–Hotline, ABVI–Goodwill, 422 

South Clinton Ave., Rochester, NY 

14620; telephone number: (202) 554– 

1404; e-mail address: TSCAHotline@epa.gov. 

SUPPLEMENTARY INFORMATION: 

I. General Information 

A. Does this action apply to me? 

This notice is directed to the public 

in general. It may, however, be of 

particular interest to you if you 

manufacture (defined by statute to 

include import) and/or process TSCAcovered chemicals and you may be 

identified by the North American 

Industrial Classification System 

(NAICS) codes 325 and 32411. Because 

this notice is directed to the general 

public and other entities may also be 

interested, the Agency has not 

attempted to describe all the specific 

entities that may be interested in this 

action. If you have any questions 

regarding the applicability of this action 

to a particular entity, consult the 

technical person listed under FOR

FURTHER INFORMATION CONTACT. 

B. What should I consider as I prepare 

my comments for EPA? 

1. Submitting CBI. Do not submit this 

information to EPA through 

regulations.gov or e-mail. Clearly mark 

the part or all of the information that 

you claim to be CBI. For CBI 

information in a disk or CD–ROM that 

you mail to EPA, mark the outside of the 

disk or CD–ROM as CBI and then 

identify electronically within the disk or 

CD–ROM the specific information that 

is claimed as CBI. In addition to one 

complete version of the comment that 

includes information claimed as CBI, a 

copy of the comment that does not 

contain the information claimed as CBI 

must be submitted for inclusion in the 

public docket. Information so marked 

will not be disclosed except in 

accordance with procedures set forth in 

40 CFR part 2. 

2. Tips for preparing your comments. 

When submitting comments, remember 

to: 

i. Identify the document by docket ID 

number and other identifying 

information (subject heading, Federal 

Register date and page number). 

ii. Follow directions. The Agency may 

ask you to respond to specific questions 

or organize comments by referencing a 

Code of Federal Regulations (CFR) part 

or section number. 


sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 46175 

iii. Explain why you agree or disagree; 

suggest alternatives and substitute 

language for your requested changes. 

iv. Describe any assumptions and 

provide any technical information and/ 

or data that you used. 

v. If you estimate potential costs or 

burdens, explain how you arrived at 

your estimate in sufficient detail to 

allow for it to be reproduced. 

vi. Provide specific examples to 

illustrate your concerns and suggest 

alternatives. 

vii. Explain your views as clearly as 

possible, avoiding the use of profanity 

or personal threats. 

viii. Make sure to submit your 

comments by the comment period 

deadline identified. 

II. Background 

The Toxic Substances Control Act 

(TSCA) (15 U.S.C. 260l et seq.) 

authorizes the Administrator of EPA to 

promulgate regulations under TSCA 

section 4(a) requiring testing of 

chemicals and chemical groups in order 

to develop data relevant to determining 

the risks that such chemicals and 

chemical groups may present to health 

or the environment. Section 4(e) of 

TSCA established the ITC to 

recommend chemicals and chemical 

groups to the Administrator of EPA for 

priority testing consideration. Section 

4(e) of TSCA directs the ITC to revise 

the TSCA section 4(e) Priority Testing 

List at least every 6 months. 

You may access additional 

information about the ITC at http:// 

www.epa.gov/opptintr/itc. 

A. The 68th ITC Report 

The ITC is adding cadmium and 103 

cadmium compounds to the TSCA 

section 4(e) Priority Testing List. During 

this reporting period (December 2010 to 

May 2011), the ITC is also removing 29 

HPV Challenge Program orphan 

chemicals and lead and 11 lead 

compounds from the Priority Testing 

List. 

B. Status of the Priority Testing List 

The Priority Testing List includes 2 

alkylphenols, 16 chemicals with 

insufficient dermal absorption rate data, 

178 HPV Challenge Program orphan 

chemicals, and cadmium and 103 

cadmium compounds. 

List of Subjects 

Environmental protection, Chemicals, 

Hazardous substances. 

Dated: July 25, 2011. 

Wendy C. Hamnett, 

Director, Office of Pollution Prevention and 

Toxics. 

Sixty-Eighth Report of the TSCA 

Interagency Testing Committee to the 

Administrator of the Environmental 

Protection Agency 

Table of Contents 

Summary 

I. Background 

II. TSCA Section 8 Reporting 

A. TSCA Section 8 Reporting Rules 

B. ITC’s Use of TSCA Section 8 and Other 

Information 

C. New Request to Add Chemicals to the 

TSCA Section 8(d) HaSDR Rule 

III. ITC’s Activities During this Reporting 

Period (December 2010 to May 2011) 

IV. Revisions to the TSCA Section 4(e) 

Priority Testing List 

A. Chemicals Added to the Priority Testing 

List: Cadmium and Cadmium 

Compounds 

B. Chemicals Removed from the Priority 

Testing List 

1. HPV Challenge Program orphan 

chemicals 

2. Lead and lead compounds 

V. References 

VI. The TSCA Interagency Testing 

Committee 

Summary 

The ITC is adding cadmium and 103 

cadmium compounds to the Toxic 

Substances Control Act (TSCA) section 

4(e) Priority Testing List during this 

reporting period (December 2010 to May 

2011). In addition, the ITC is removing 

29 HPV Challenge Program orphan 

chemicals, lead and 11 lead compounds 

from the Priority Testing List during this 

reporting period. 

The TSCA section 4(e) Priority Testing 

List is Table 1 of this unit. 

TABLE 1—TSCA SECTION 4(E) PRIORITY TESTING LIST (MAY 2011) 

ITC Report No. Date Chemical name/group Action 

31 .......................... January 1993 .............. 2 Chemicals with insufficient dermal absorption rate data, methylcyclohexane 

and cyclopentane.

Designated. 

32 .......................... May 1993 .................... 10 Chemicals with insufficient dermal absorption rate data ............................... Designated. 

35 .......................... November 1994 .......... 4 Chemicals with insufficient dermal absorption rate data, cyclopentadiene, 

formamide, 1,2,3-trichloropropane and m-nitrotoluene.

Designated. 

37 .......................... November 1995 .......... Branched 4-nonylphenol (mixed isomers) .......................................................... Recommended. 

41 .......................... November 1997 .......... Phenol, 4-(1,1,3,3-tetramethylbutyl)- ................................................................... Recommended. 

55 .......................... December 2004 .......... 175 High Production Volume (HPV) Challenge Program orphan chemicals ..... Recommended. 

56 .......................... August 2005 ................ 3 HPV Challenge Program orphan chemicals .................................................... Recommended. 

68 .......................... May 2011 .................... Cadmium and 103 cadmium compounds ........................................................... Recommended. 

I. Background 

The ITC was established by TSCA 

section 4(e) ‘‘to make recommendations 

to the Administrator respecting the 

chemical substances and mixtures to 

which the Administrator should give 

priority consideration for the 

promulgation of rules for testing under 

section 4(a)* * *. At least every six 

months * * *, the Committee shall 

make such revisions to the Priority 

Testing List as it determines to be 

necessary and transmit them to the 

Administrator together with the 

Committee’s reasons for the revisions’’ 

(Pub. L. 94–469, 90 Stat. 2003 et seq., 15 

U.S.C. 2601 et seq.). ITC reports are 

available from regulations.gov (http:// 

www.regulations.gov) after publication 

in the Federal Register. The ITC 

produces its revisions to the Priority 

Testing List with administrative and 

technical support from the ITC staff, ITC 

members, and their U.S. Government 

organizations, and contract support 

provided by EPA. ITC members and 

staff are listed at the end of this report. 

II. TSCA Section 8 Reporting 

A. TSCA Section 8 Reporting Rules 

Following receipt of the ITC’s report 

(and the revised Priority Testing List) by 

the EPA Administrator, the EPA’s Office 

of Pollution Prevention and Toxics 

(OPPT) may add the chemicals from the 

revised Priority Testing List to the TSCA 

section 8(a) Preliminary Assessment 

Information Reporting (PAIR) or the 

TSCA section 8(d) Health and Safety 

Data Reporting (HaSDR) rules. The PAIR 

rule requires manufacturers (including 

importers) of chemicals added to the 


sroberts on DSK5SPTVN1PROD with NOTICES
46176 Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 

1ATSDR Toxicological Profile for Cadmium 

(Draft). Agency for Toxic Substances and Disease 

Registry. U.S. Department of Health and Human 

Services. 2008. Available on-line at: http:// 

www.atsdr.cdc.gov/substances/ 

toxsubstance.asp?toxid=15. 

2CPSC. Staff Briefing Package. Petition HP 10–2. 

Requesting Restriction of Cadmium in Toy Jewelry 

Consumer Product Safety Commission. February 9, 

2011. Staff Report, Cadmium in Children’s Metal 

Jewelry. Toxicity Review of Cadmium. TAB B pp. 

19–39. October 14, 2010. Available on-line at: 

http://www.cpsc.gov/library/foia/foia11/brief/ 

cadmiumpet.pdf. 

3McDonald’s Recalls Movie Themed Drinking 

Glasses Due to Potential Cadmium Risk. Available 

on-line at: http://www.cpsc.gov/CPSCPUB/PREREL/ 

prhtml10/10257.html. Last visited March 4, 2011. 

Priority Testing List to submit to EPA 

certain production and exposure 

information (http://www.epa.gov/oppt/ 

chemtest/pubs/pairform.pdf). The 

HaSDR rule requires manufacturers 

(including importers) of chemicals 

added to the Priority Testing List to 

submit unpublished health and safety 

studies to EPA. 

B. ITC’s Use of TSCA Section 8 and 

Other Information 

The ITC’s use of TSCA section 8 and 

other information is described in the 

ITC’s 52nd Report (Ref. 1). 

C. New Request To Add Chemicals to 

the TSCA Section 8(d) HaSDR Rule 

The ITC is requesting that EPA add 

the category of cadmium and cadmium 

compounds, including specifically 

cadmium and 103 cadmium compounds 

to the TSCA section 8(d) HaSDR rule. 

Cadmium and cadmium compounds are 

discussed in Unit IV. of this report. 

III. ITC’s Activities During This 

Reporting Period (December 2010 to 

May 2011) 

During this reporting period, the ITC 

discussed the draft TSCA section 4 

proposed test rule, draft TSCA section 

8(a) proposed reporting rule, and draft 

proposed TSCA section 5(a) Significant 

New Use Rule for nanoscale materials. 

In addition, the ITC discussed adding 

cadmium and cadmium compounds to 

the Priority Testing List and removing 

HPV Challenge Program orphan 

chemicals and lead and lead 

compounds from the Priority Testing 

List. 

IV. Revisions to the TSCA Section 4(e) 

Priority Testing List 

A. Chemicals Added to the Priority 

Testing List: Cadmium and Cadmium 

Compounds 

1. Recommendation. EPA requests 

that the ITC add the category ‘‘cadmium 

and cadmium compounds’’ to the 

Priority Testing List to obtain use and 

exposure information on cadmium and 

cadmium compounds that are present in 

any consumer product. 

Required information would be 

limited to unpublished health and 

safety studies, including those relating 

to the cadmium content in consumer 

products containing cadmium or 

cadmium compounds, and/or studies 

that assess exposure to cadmium or 

cadmium compounds from such 

products. Exposure studies include any 

studies providing information about the 

solubility, bioavailability, and duration 

of exposure to cadmium or cadmium 

compounds from product use. 

2. Rationale for recommendation. 

EPA and the Consumer Product Safety 

Commission (CPSC) are concerned with 

the content of cadmium or cadmium 

compounds in certain children’s toys, 

jewelry, and other consumer products 

due to known toxicity and health 

concerns from exposure to cadmium or 

cadmium compounds. CPSC and EPA 

have limited health and safety studies 

on the content of cadmium or cadmium 

compounds in consumer products. EPA 

is recommending that the ITC include 

the category listing for cadmium and 

cadmium compounds described in this 

unit. This will provide both EPA and 

CPSC with a streamlined means of 

obtaining studies. Information obtained 

on this category may assist both EPA 

and CPSC in taking further action as 

appropriate to protect consumers from 

exposure to cadmium or cadmium 

compounds in consumer products. 

3. Supporting information. The acute 

(short-term) effects of cadmium in 

humans through inhalation exposure 

consist mainly of effects on the lung, 

such as pulmonary irritation. Chronic 

(long-term) inhalation or oral exposure 

to cadmium leads to a build-up of 

cadmium in the kidneys that can cause 

kidney disease. 

Cadmium has been shown to be a 

developmental toxicant in animals, 

resulting in fetal malformations and 

other effects, but no conclusive 

evidence exists in humans. Animal 

studies have demonstrated an increase 

in lung cancer from long-term 

inhalation exposure to cadmium.1 EPA 

has classified cadmium as a Group B1, 

probable human carcinogen (http:// 

epa.gov/ttn/atw/hlthef/cadmium.html). 

Cadmium has been found in certain 

consumer products: In 2010, CPSC 

found the amount of cadmium in 

samples of children’s metal jewelry 

ranged from about 0.03 to 99% by 

weight. CPSC also assessed potential 

exposures to cadmium by extraction 

testing, including using an acid solution 

to simulate the effect of stomach acid. 

The CPSC Staff found that potential 

exposure to cadmium would exceed the 

acceptable daily intake levels for acute 

exposure to a child. CPSC recalled 26 

items of jewelry in 4 separate recalls 

and issued a warning about 2 additional 

jewelry items.2 Cadmium was also 

found in the paint on glassware. CPSC 

issued a voluntary recall of 12 million 

‘‘Shrek’’ movie themed collectable 

drinking glasses.3

Due to the potential health effects of 

exposure to cadmium or cadmium 

compounds, EPA and CPSC are 

concerned about the possible presence 

and bioavailability of cadmium or 

cadmium compounds in consumer 

products generally. However, neither 

CPSC nor EPA currently has complete 

information for assessing the safety of 

any other consumer products that may 

contain cadmium or cadmium 

compounds. 

4. Information needs. EPA needs 

health and safety studies for assessing 

the extent and degree of exposure and 

potential hazard associated with these 

substances including: Epidemiological 

or clinical studies, occupational 

exposure and health effects studies, 

ecological effects studies, and 

environmental fate studies (including 

relevant physical chemical properties). 

Specifically EPA needs studies about 

the total amount of cadmium or 

cadmium compounds contained in a 

product, the solubility and 

bioavailability of cadmium or cadmium 

compounds (including accessibility of 

cadmium or cadmium compounds to 

children and studies of the age and 

foreseeable behavior of children 

exposed to a product for children and/ 

or children’s toys), the foreseeable 

duration and route of potential 

cadmium or cadmium compounds 

exposure through contact with products, 

and studies on the marketing, patterns 

of use, and lifecycle of cadmiumcontaining products. 

TABLE 2—CADMIUM AND CADMIUM COMPOUNDS BEING ADDED TO THE PRIORITY TESTING LIST

CAS No. Cadmium and cadmium compounds 

506–82–1 ................................................................................................................ Cadmium, dimethylVerDate Mar<15>2010 21:20 Jul 29, 2011 Jkt 223001 PO 00000 Frm 00004 Fmt 4701 Sfmt 4703 E:\FR\FM\01AUN2.SGM 01AUN2

sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 46177 

TABLE 2—CADMIUM AND CADMIUM COMPOUNDS BEING ADDED TO THE PRIORITY TESTING LIST—Continued 

CAS No. Cadmium and cadmium compounds 

513–78–0 ................................................................................................................ Carbonic acid, cadmium salt (1:1) 

542–83–6 ................................................................................................................ Cadmium cyanide (Cd(CN)2) 

543–90–8 ................................................................................................................ Acetic acid, cadmium salt (2:1) 

592–02–9 ................................................................................................................ Cadmium, diethyl1306–19–0 .............................................................................................................. Cadmium oxide (CdO) 

1306–23–6 .............................................................................................................. Cadmium sulfide (CdS) 

1306–24–7 .............................................................................................................. Cadmium selenide (CdSe) 

1306–25–8 .............................................................................................................. Cadmium telluride (CdTe) 

2191–10–8 .............................................................................................................. Octanoic acid, cadmium salt (2:1) 

2223–93–0 .............................................................................................................. Octadecanoic acid, cadmium salt (2:1) 

2420–97–5 .............................................................................................................. Benzoic acid, 4-methyl-, cadmium salt (2:1) 

2420–98–6 .............................................................................................................. Hexanoic acid, 2-ethyl-, cadmium salt (2:1) 

2847–16–7 .............................................................................................................. Decanoic acid, cadmium salt (2:1) 

3026–22–0 .............................................................................................................. Benzoic acid, cadmium salt (2:1) 

4167–05–9 .............................................................................................................. Benzoic acid, 4-(1,1-dimethylethyl)-, cadmium salt (2:1) 

4464–23–7 .............................................................................................................. Formic acid, cadmium salt 

5112–16–3 .............................................................................................................. Nonanoic acid, cadmium salt (2:1) 

6427–86–7 .............................................................................................................. Hexadecanoic acid, cadmium salt (2:1) 

7440–43–9 .............................................................................................................. Cadmium 

7789–42–6 .............................................................................................................. Cadmium bromide (CdBr2) 

7790–79–6 .............................................................................................................. Cadmium fluoride (CdF2) 

7790–80–9 .............................................................................................................. Cadmium iodide (CdI2) 

7790–85–4 .............................................................................................................. Cadmium tungsten oxide (CdWO4) 

10108–64–2 ............................................................................................................ Cadmium chloride (CdCl2) 

10124–36–4 ............................................................................................................ Sulfuric acid, cadmium salt (1:1) 

10196–67–5 ............................................................................................................ Tetradecanoic acid, cadmium salt (2:1) 

10325–94–7 ............................................................................................................ Nitric acid, cadmium salt (2:1) 

10326–28–0 ............................................................................................................ Perchloric acid, cadmium salt, hexahydrate 

10468–30–1 ............................................................................................................ 9-Octadecenoic acid (9Z)-, cadmium salt (2:1) 

12006–15–4 ............................................................................................................ Cadmium arsenide (Cd3As2) 

12014–28–7 ............................................................................................................ Cadmium phosphide (Cd3P2) 

12014–29–8 ............................................................................................................ Antimony, compd. with cadmium (2:3) 

12139–22–9 ............................................................................................................ Cadmium peroxide (Cd(O2)) 

12139–23–0 ............................................................................................................ Cadmium zirconium oxide (CdZrO3) 

12185–64–7 ............................................................................................................ Cadmium chloride phosphate (Cd5Cl(PO4)3) 

12187–14–3 ............................................................................................................ Cadmium niobium oxide (Cd2Nb2O7) 

12292–07–8 ............................................................................................................ Cadmium tantalum oxide (CdTa2O6) 

12442–27–2 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S) 

12626–36–7 ............................................................................................................ Cadmium selenide sulfide (Cd(Se,S)) 

13477–17–3 ............................................................................................................ Phosphoric acid, cadmium salt (2:3) 

13477–19–5 ............................................................................................................ Silicic acid (H2SiO3), cadmium salt (1:1) 

13814–59–0 ............................................................................................................ Selenious acid, cadmium salt (1:1) 

13847–17–1 ............................................................................................................ Phosphoric acid, cadmium salt (1:?) 

14017–36–8 ............................................................................................................ Sulfamic acid, cadmium salt (2:1) 

14486–19–2 ............................................................................................................ Borate(1-), tetrafluoro-, cadmium (2:1) 

14520–70–8 ............................................................................................................ Phosphoric acid, ammonium cadmium salt (1:1:1) 

15600–62–1 ............................................................................................................ Diphosphoric acid, cadmium salt (1:2) 

15851–44–2 ............................................................................................................ Telluric acid (H2TeO3), cadmium salt (1:1) 

15852–14–9 ............................................................................................................ Telluric acid (H2TeO4), cadmium salt (1:1) 

16056–72–7 ............................................................................................................ Cadmium vanadium oxide (CdV2O6) 

19262–93–2 ............................................................................................................ Diphosphoric acid, cadmium salt (1:?) 

21041–95–2 ............................................................................................................ Cadmium hydroxide (Cd(OH)2) 

27476–27–3 ............................................................................................................ Benzoic acid, methyl-, cadmium salt (2:1) 

29870–72–2 ............................................................................................................ Cadmium mercury telluride ((Cd,Hg)Te) 

34303–23–6 ............................................................................................................ Docosanoic acid, cadmium salt (2:1) 

51222–60–7 ............................................................................................................ Boric acid, cadmium salt 

52337–78–7 ............................................................................................................ Benzoic acid, 2-methyl-, cadmium salt (2:1) 

61789–34–2 ............................................................................................................ Naphthenic acids, cadmium salts 

68092–45–5 ............................................................................................................ Benzoic acid, 3-methyl-, cadmium salt (2:1) 

68131–58–8 ............................................................................................................ Fatty acids, C10–18, cadmium salts 

68131–59–9 ............................................................................................................ Fatty acids, C12–18, cadmium salts 

68332–81–0 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), copper and lead-doped 

68409–82–5 ............................................................................................................ Fatty acids, C14–18, cadmium salts 

68478–53–5 ............................................................................................................ Cadmium, benzoate p-tert-butylbenzoate complexes 

68479–13–0 ............................................................................................................ Pyrochlore, bismuth cadmium ruthenium 

68512–49–2 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), copper chloride-doped 

68512–50–5 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), copper and manganesedoped 

68512–51–6 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), aluminum and copper-doped 

68583–43–7 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), copper and silver-doped 

68583–44–8 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), nickel and silver-doped 

68583–45–9 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), silver chloride-doped 


sroberts on DSK5SPTVN1PROD with NOTICES
46178 Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 

TABLE 2—CADMIUM AND CADMIUM COMPOUNDS BEING ADDED TO THE PRIORITY TESTING LIST—Continued 

CAS No. Cadmium and cadmium compounds 

68584–41–8 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), aluminum and silver-doped 

68584–42–9 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), copper and nickel-doped 

68784–10–1 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), aluminum and cobalt and 

copper and silver-doped 

68784–55–4 ............................................................................................................ Barium cadmium calcium chloride fluoride phosphate, antimony and manganese-doped 

68784–58–7 ............................................................................................................ Cadmium borate oxide (Cd3(BO2)4O), manganese-doped 

68855–80–1 ............................................................................................................ Fatty acids, tall-oil, cadmium salts 

68876–84–6 ............................................................................................................ Fatty acids, C8–18 and C18-unsatd., cadmium salts 

68876–90–4 ............................................................................................................ Barium cadmium zinc sulfide (Ba2(Cd,Zn)S3), manganesedoped 

68876–98–2 ............................................................................................................ Cadmium sulfide (CdS), aluminum and copper-doped 

68876–99–3 ............................................................................................................ Cadmium sulfide (CdS), aluminum and silver-doped 

68877–00–9 ............................................................................................................ Cadmium sulfide (CdS), copper chloride-doped 

68877–01–0 ............................................................................................................ Cadmium sulfide (CdS), silver chloride-doped 

68891–87–2 ............................................................................................................ Cadmium sulfide (CdS), copper and lead-doped 

68953–39–9 ............................................................................................................ Fatty acids, tallow, hydrogenated, cadmium salts 

68954–18–7 ............................................................................................................ Cadmium, laurate palmitate stearate complexes 

68956–81–0 ............................................................................................................ Resin acids and Rosin acids, cadmium salts 

69011–66–1 ............................................................................................................ Bismuth alloy, nonbase, Bi,Cd, dross 

69011–67–2 ............................................................................................................ Bismuth alloy, nonbase, Bi,Cd,In, dross 

69011–69–4 ............................................................................................................ Cadmium, dross 

69011–70–7 ............................................................................................................ Cadmium, sponge 

69012–57–3 ............................................................................................................ Flue dust, cadmium-refining 

69029–63–6 ............................................................................................................ Calcines, cadmium residue 

69029–70–5 ............................................................................................................ Leach residues, cadmium-refining 

69029–77–2 ............................................................................................................ Residues, cadmium-refining 

70084–75–2 ............................................................................................................ Fatty acids, C12–18, barium cadmium salts 

71243–75–9 ............................................................................................................ Cadmium selenide sulfide (CdSe0.53S0.47) 

72828–62–7 ............................................................................................................ Zircon, cadmium red 

72869–26–2 ............................................................................................................ Cadmium zinc sulfide ((Cd,Zn)S), cobalt and copper-doped 

72869–63–7 ............................................................................................................ Fatty acids, coco, cadmium salts 

72968–34–4 ............................................................................................................ Zircon, cadmium yellow 

93894–08–7 ............................................................................................................ Phenol, 4-nonyl-, cadmium salt (2:1) 

135742–32–4 .......................................................................................................... Fatty acids, C6–12, cadmium salts 

B. Chemicals Removed From the Priority 

Testing List 

1. HPV Challenge Program orphan 

chemicals. Two hundred seventy (270) 

HPV Challenge Program orphan 

chemicals were added to the Priority 

Testing List in the 55th ITC Report (Ref. 

2) and 5 were added to the Priority 

Testing List in the 56th ITC Report (Ref. 

3). 

Thirty (30) HPV Challenge Program 

orphan chemicals were removed from 

the Priority Testing List in the 56th ITC 

Report. Eight (8) HPV Challenge 

Program orphan chemicals were 

removed from the Priority Testing List in 

the 58th ITC Report (Ref. 4). Thirty-five 

(35) HPV Challenge Program orphan 

chemicals were removed from the 

Priority Testing List in the 61st ITC 

Report (Ref. 5). One HPV Challenge 

Program Orphan chemical was removed 

from the Priority Testing List in the 63rd 

ITC Report (Ref. 6). 

In this ITC report 29 HPV Challenge 

Program orphan chemicals are being 

removed from the Priority Testing List 

because they were included in the 

EPA’s TSCA section 4 proposed test rule 

(Ref. 7). (See Table 3 of this unit.) 

TABLE 3—TWENTY-NINE HPV CHALLENGE PROGRAM ORPHAN CHEMICALS BEING REMOVED FROM THE PRIORITY TESTING

LIST

CAS No. Chemical name 

83-41–0 ................... Benzene, 1,2-dimethyl-3-nitro96–22–0 .................. 3-Pentanone 

98–09–9 .................. Benzenesulfonyl chloride 

98–56–6 .................. Benzene, 1-chloro-4-(trifluoromethyl)- 

111–44–4 ................ Ethane, 1,1′-oxybis[2-chloro-] 

127–68–4 ................ Benzenesulfonic acid, 3-nitro-, sodium salt (1:1) 

506–51–4 ................ 1-Tetracosanol 

506–52–5 ................ 1-Hexacosanol 

515–40–2 ................ Benzene, (2-chloro-1,1-dimethylethyl)- 

2494–89–5 .............. Ethanol, 2-[(4-aminophenyl)sulfonyl]-, 1-(hydrogen sulfate) 

5026–74–4 .............. 2-Oxiranemethanamine, N-[4-(2-oxiranylmethoxy)phenyl]-N-(2-oxiranylmethyl)- 

22527–63–5 ............ Propanoic acid, 2-methyl-, 3-(benzoyloxy)-2,2,4-trimethylpentyl ester 

24615–84–7 ............ 2-Propenoic acid, 2-carboxyethyl ester 

25321–41–9 ............ Benzenesulfonic acid, dimethyl25646–71–3 ............ Methanesulfonamide, N-[2-[(4-amino-3-methylphenyl)ethylamino] ethyl]-, sulfate (2:3) 

52556–42–0 ............ 1-Propanesulfonic acid, 2-hydroxy-3-(2-propen-1-yloxy)-, sodium salt (1:1) 


sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 46179 

TABLE 3—TWENTY-NINE HPV CHALLENGE PROGRAM ORPHAN CHEMICALS BEING REMOVED FROM THE PRIORITY TESTING

LIST—Continued 

CAS No. Chemical name 

61788–76–9 ............ Alkanes, chloro 

65996–79–4 ............ Solvent naphtha (coal) 

65996–82–9 ............ Tar oils, coal 

65996–89–6 ............ Tar, coal, high-temp. 

65996–92–1 ............ Distillates (coal tar) 

68082–78–0 ............ Lard, oil, Me esters 

68187–57–5 ............ Pitch, coal tar-petroleum 

68442–60–4 ............ Acetaldehyde, reaction products with formaldehyde, by-products from 

68610–90–2 ............ 2-Butenedioic acid (2E)-, di-C8-18-alkyl esters 

68988–22–7 ............ 1,4-Benzenedicarboxylic acid, 1,4-dimethyl ester, manuf. of, by-products from 

70693–50–4 ............ Phenol, 2,4-bis(1-methyl-1-phenylethyl)-6-[2-(2-nitrophenyl)diazenyl]- 

72162–15–3 ............ 1-Decene, sulfurized 

73665–18–6 ............ Extract residues (coal), tar oil alk., naphthalene distn. residues 

2. Lead and lead compounds. Lead 

and lead compounds were added to the 

Priority Testing List in the ITC’s 60th 

Report to obtain unpublished health and 

safety studies that relate to the lead 

content of consumer products that are 

‘‘intended for use by children’’ and 

studies that assess children’s exposure 

to lead from such products (Ref. 8). At 

this time the ITC is removing lead and 

lead compounds from the Priority 

Testing List because the EPA has 

reviewed the unpublished health and 

safety studies submitted in response to 

the TSCA section 8(d) HaSDR rule (Ref. 

9). 

TABLE 4—LEAD AND LEAD COMPOUNDS BEING REMOVED FROM THE PRIORITY TESTING LIST

CAS No. Chemical Name 

301–04–2 ......................................................................................................................................... Acetic acid, lead(2+) salt (2:1) 

598–63–0 ......................................................................................................................................... Carbonic acid, lead(2+) salt (1:1) 

1309–60–0 ....................................................................................................................................... Lead oxide (PbO2) 

1314–87–0 ....................................................................................................................................... Lead sulfide (PbS) 

7428–48–0 ....................................................................................................................................... Octadecanoic acid, lead salt (1:?) 

7439–92–1 ....................................................................................................................................... Lead 

7446–27–7 ....................................................................................................................................... Phosphoric acid, lead(2+) salt (2:3) 

7758–95–4 ....................................................................................................................................... Lead chloride (PbCl2) 

7758–97–6 ....................................................................................................................................... Chromic acid (H2CrO4), lead(2+) salt (1:1) 

13814–96–5 ..................................................................................................................................... Borate(1-), tetrafluoro-, lead(2+) (2:1) 

53466–66–3 ..................................................................................................................................... Silicic acid, lead salt, basic 

63653–42–9 ..................................................................................................................................... Sulfuric acid, lead salt (1:?), basic 

V. References 

1. ITC. Fifty-Second Report of the ITC; 

Notice. Federal Register (68 FR 43608, 

July 23, 2003) (FRL–7314–4). Available 

on-line at: http://www.gpoaccess.gov/fr. 

2. ITC. Fifty-Fifth Report of the ITC; 

Notice. Federal Register (70 FR 7364, 

February 11, 2005) (FRL–7692–1). 

Available on-line at: http:// 

www.gpoaccess.gov/fr. 

3. ITC. Fifty-Sixth Report of the ITC; 

Notice. Federal Register (70 FR 61520, 

October 24, 2005) (FRL–7739–9). 

Available on-line at: http:// 

www.gpoaccess.gov/fr. 

4. ITC. Fifty-Eighth Report of the ITC; 

Notice. Federal Register (71 FR 39188, 

July 11, 2006) (FRL–8073–7). Available 

on-line at: http://www.gpoaccess.gov/fr. 

5. ITC. Sixty-First Report of the ITC; 

Notice. Federal Register (73 FR 5080, 

January 28, 2008) (FRL–8347–1). 

Available on-line at: http:// 

www.gpoaccess.gov/fr. 

6. ITC. Sixty-Third Report of the ITC; 

Notice. Federal Register (73 FR 65486, 

November 3, 2008) (FRL–8387–6). 

Available on-line at: http:// 

www.gpoaccess.gov/fr. 

7. EPA. Testing of Certain High 

Production Volume Chemicals; Third 

Group of Chemicals; Proposed rule. 

Federal Register (75 FR 8575, February 

25, 2010) (FRL–8805–8). Available online at: http://www.gpoaccess.gov/fr. 

8. ITC. Sixtieth Report of the ITC; 

Notice. Federal Register (72 FR 41414, 

July 27, 2007) (FRL–8137–6). Available 

online at: http://www.gpoaccess.gov/fr. 

9. EPA. Health and Safety Data 

Reporting; Addition of Certain 

Chemicals; Final rule. Federal Register 

(73 FR 5109, January 29, 2008) (FRL– 

8154–2). Available on-line at: http:// 

www.gpoaccess.gov/fr. 

VI. The TSCA Interagency Testing 

Committee 

Statutory Organizations and Their 

Representatives 

Council on Environmental Quality 

Vacant. 

Department of Commerce 

National Institute of Standards and 

Technology 

Dianne L. Poster, Alternate. 

National Oceanographic and 

Atmospheric Administration 

Kimani Kimbrough, Member. 

Anthony S. Pait, Alternate. 

Environmental Protection Agency 

Robert W. Jones, Member. 

John E. Schaeffer, Alternate. 

National Cancer Institute 

Vacant. 


sroberts on DSK5SPTVN1PROD with NOTICES
46180 Federal Register / Vol. 76, No. 147 / Monday, August 1, 2011 / Notices 

National Institute of Environmental 

Health Sciences 

Nigel Walker, Member. 

Scott Masten, Alternate. 

National Institute for Occupational 

Safety and Health 

Gayle DeBord, Member. 

Dennis W. Lynch, Alternate. 

National Science Foundation 

Vacant. 

Occupational Safety and Health 

Administration 

Thomas Nerad, Member, Chair. 

Liaison Organizations and Their 

Representatives 

Agency for Toxic Substances and 

Disease Registry 

Daphne Moffett, Member. 

Glenn D. Todd, Alternate. 

Consumer Product Safety Commission 

Dominique Williams, Member. 

Department of Agriculture 

Clifford P. Rice, Member, Vice-Chair. 

Laura L. McConnell, Alternate. 

Department of Defense 

Laurie E. Roszell, Member. 

Department of the Interior 

Barnett A. Rattner, Member. 

Food and Drug Administration 

Kirk Arvidson, Member. 

Ronald F. Chanderbhan, Alternate. 

ITC Staff 

John D. Walker, Director. 

Carol Savage, Administrative 

Assistant (NOWCC Employee). 

TSCA Interagency Testing Committee 

(7401M), Office of Pollution Prevention 

and Toxics, Environmental Protection 

Agency, 1200 Pennsylvania Ave., NW., 

Washington, DC 20460–0001; e-mail 

address: savage.carol@epa.gov; url: 

http://www.epa.gov/opptintr/itc. [FR Doc. 2011–19414 Filed 7–29–11; 8:45 am] 

BILLING CODE 6560–50–P 


sroberts on DSK5SPTVN1PROD with NOTICES